Breaking

Ofra Strauss Joins Top Gum’s Board of Directors

Strauss Group chairwoman joins the board of Top Gum, a maker of gummy dietary supplements traded on the Tel Aviv Stock Exchange (TASE) • The company, which began in Sderot and expanded to the U.S. and Canada, recorded a 65% surge in revenue in the first half of 2026, totaling about $65.7 million

Businesswoman Ofra Strauss
Businesswoman Ofra Strauss | Photo: Avshalom Sassoni, Flash90

Ofra Strauss, chairwoman of Strauss Group, is joining the board of Top Gum, which develops and manufactures dietary supplements in gummy form for leading brands worldwide. The appointment comes amid the expansion of the company’s international operations. It began in Sderot and in recent years has become a player in the global dietary supplements market.

Strauss has served as chairwoman of Strauss Group since 2001 and will now bring her business and management experience to the board of the company, which is undergoing rapid expansion. The connection between the two sides is based, among other things, on their ties to Israeli industry and the Negev: Like Strauss Group, Top Gum continues to maintain manufacturing operations in Israel while expanding into international markets.

Top Gum factory
Top Gum factory | Photo: Top Gum

“I am pleased to join Top Gum’s board of directors. I have always believed in the power of Israeli companies to grow from here and build a significant presence worldwide while maintaining their connection to the place and the people from which they grew,” Strauss said. “As an innovative company growing from Sderot to the world, Top Gum represents precisely that connection for me.”

Raviv Zoller, chairman of Top Gum’s board of directors, welcomed the appointment and said Strauss’ experience leading Strauss Group and expanding its operations in international markets is expected to assist the company at its current stage of development.

65% surge in first-half revenue

The appointment comes during a period of significant growth at Top Gum. In the second quarter of 2026, the company recorded its 10th consecutive record quarter, with revenue of about $33.8 million and organic growth of about 50%.

In the first half of the year, the group’s revenue totaled about $65.7 million, an increase of about 65% compared with the corresponding period. At the same time, the order backlog in the dietary supplements segment reached a record of about $57 million. The company estimates that the second half of the year will reflect an annual sales run rate of more than $145 million.

Top Gum, founded in 2004, manufactures gummies containing vitamins, minerals and nutritional ingredients for international brands. In November 2025, the company began commercial operations at a new, advanced factory in Sderot. It currently operates manufacturing sites in Israel, Canada and the U.S. and employs more than 400 people.

Top Gum factory
Top Gum factory | Photo: Top Gum

Expansion into the U.S. and entry into pharmaceuticals

One of the key moves in the company’s growth strategy was the acquisition of Canadian company Island Abbey’s operations in 2025. In May 2026, Top Gum completed another acquisition, purchasing the U.S. gummy manufacturing operations of P&L Development.

The acquisition gave the company a physical presence for the first time in the U.S. market, its main target market, as well as a foothold in pharmaceuticals. The moves were intended to expand its manufacturing and distribution capabilities and strengthen its position with international brands.

Strauss’ appointment joins a series of senior appointments made by the company in recent years. Among others, Raviv Zoller, former CEO of ICL, was appointed executive chairman of the board, and Eyal Shohat, former CEO of SodaStream, was appointed CEO of the company.

Key takeaways

  • Ofra Strauss, chairwoman of Strauss Group, is joining the board of Top Gum.
  • Top Gum says the appointment comes as the company expands internationally while keeping manufacturing in Israel.
  • The company reported about $65.7 million in revenue in the first half of 2026, up about 65% from the same period.
  • Top Gum recorded its 10th consecutive record quarter in Q2 2026, with revenue of about $33.8 million and organic growth of about 50%.
  • The company says its order backlog in dietary supplements reached a record of about $57 million and it expects an annual sales run rate of more than $145 million.

Questions and answers

Why is Ofra Strauss joining Top Gum’s board?
Top Gum says Strauss is joining as the company expands internationally. The board said her experience leading Strauss Group and growing it in global markets is expected to help Top Gum at its current stage.
How has Top Gum been performing financially?
In the first half of 2026, Top Gum reported revenue of about $65.7 million, up about 65% year over year. In Q2 2026, it posted revenue of about $33.8 million and its 10th consecutive record quarter.
What recent expansion moves has Top Gum made?
Top Gum began commercial operations at a new factory in Sderot in November 2025. It also acquired Island Abbey’s operations in Canada in 2025 and P&L Development’s gummy manufacturing operations in the U.S. in May 2026.

Share this story

About the writer

TV10 Desk

Writes for TV10, Israel’s economic channel. This story was translated from the original Hebrew.

More stories by TV10 Desk

More for you